Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

72 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
A Multicenter Randomized Controlled Trial of Rituximab versus Cyclosporine in the Treatment of Idiopathic Membranous Nephropathy (MENTOR).
Fervenza FC, Canetta PA, Barbour SJ, Lafayette RA, Rovin BH, Aslam N, Hladunewich MA, Irazabal MV, Sethi S, Gipson DS, Reich HN, Brenchley P, Kretzler M, Radhakrishnan J, Hebert LA, Gipson PE, Thomas LF, McCarthy ET, Appel GB, Jefferson JA, Eirin A, Lieske JC, Hogan MC, Greene EL, Dillon JJ, Leung N, Sedor JR, Rizk DV, Blumenthal SS, Lasic LB, Juncos LA, Green DF, Simon J, Sussman AN, Philibert D, Cattran DC; Mentor Consortium group. Fervenza FC, et al. Among authors: dillon jj. Nephron. 2015;130(3):159-68. doi: 10.1159/000430849. Epub 2015 Jun 12. Nephron. 2015. PMID: 26087670 Clinical Trial.
Use of sevelamer hydrochloride as an oxalate binder.
Lieske JC, Regnier C, Dillon JJ. Lieske JC, et al. Among authors: dillon jj. J Urol. 2008 Apr;179(4):1407-10. doi: 10.1016/j.juro.2007.11.062. Epub 2008 Mar 4. J Urol. 2008. PMID: 18289565 Free PMC article. Clinical Trial.
Rituximab therapy in idiopathic membranous nephropathy: a 2-year study.
Fervenza FC, Abraham RS, Erickson SB, Irazabal MV, Eirin A, Specks U, Nachman PH, Bergstralh EJ, Leung N, Cosio FG, Hogan MC, Dillon JJ, Hickson LJ, Li X, Cattran DC; Mayo Nephrology Collaborative Group. Fervenza FC, et al. Among authors: dillon jj. Clin J Am Soc Nephrol. 2010 Dec;5(12):2188-98. doi: 10.2215/CJN.05080610. Epub 2010 Aug 12. Clin J Am Soc Nephrol. 2010. PMID: 20705965 Free PMC article.
Low- and high-molecular-weight urinary proteins as predictors of response to rituximab in patients with membranous nephropathy: a prospective study.
Irazabal MV, Eirin A, Lieske J, Beck LH, Sethi S, Borland TM, Dillon JJ, Nachman PH, Nasr SH, Cornell LD, Leung N, Cattran DC, Fervenza FC. Irazabal MV, et al. Among authors: dillon jj. Nephrol Dial Transplant. 2013 Jan;28(1):137-46. doi: 10.1093/ndt/gfs379. Epub 2012 Sep 17. Nephrol Dial Transplant. 2013. PMID: 22987142 Free PMC article.
C3 glomerulonephritis associated with complement factor B mutation.
Sethi S, Smith RJ, Dillon JJ, Fervenza FC. Sethi S, et al. Among authors: dillon jj. Am J Kidney Dis. 2015 Mar;65(3):520-1. doi: 10.1053/j.ajkd.2014.10.023. Epub 2014 Dec 18. Am J Kidney Dis. 2015. PMID: 25532781 No abstract available.
Incidence of Adverse Events during Continuous Renal Replacement Therapy.
Akhoundi A, Singh B, Vela M, Chaudhary S, Monaghan M, Wilson GA, Dillon JJ, Cartin-Ceba R, Lieske JC, Gajic O, Kashani K. Akhoundi A, et al. Among authors: dillon jj. Blood Purif. 2015;39(4):333-9. doi: 10.1159/000380903. Epub 2015 May 22. Blood Purif. 2015. PMID: 26022612
72 results